4.610USD-3.15%Mkt Cap: —P/E: 1.551d ago
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationall…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap—
Enterprise Value683.84M $
Revenue (TTM)770.20M $
Gross Profit380.40M $
Net Income (TTM)-176.80M $
Revenue/Share14.76 USD
Last Price4.610 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees900
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS29089Q1058
Valuation
P/E (Trailing)1.55
P/E (Forward)—
PEG—
EV/EBITDA2.94
EV/Revenue0.89
P/S—
P/B0.69
EPS (TTM)2.97
EPS (Forward)—
52W Range
4.46033% of range4.920
52W High4.920 USD
52W Low4.460 USD
Profitability
Gross Margin49.39%
Oper. Margin28.34%
EBITDA Margin30.17%
Profit Margin-22.96%
ROE-40.29%
ROA6.93%
Growth
Revenue Growth66.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF97.70M $
CapEx (TTM)—
FCF Margin4.87%
FCF Yield—
Net Debt448.50M $
Net Debt/EBITDA1.93
Balance Sheet
Debt/Equity172.29
Current Ratio5.42
Quick Ratio2.69
Book Value/Sh6.655 USD
Cash/Share2.725 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.50.95M
Float49.06M
Insiders4.26%
Institutions90.67%
Technical
SMA 502.240 (+105.8%)
SMA 2004.133 (+11.5%)
Beta2.36
S&P 52W Chg20.80%
Avg Vol (30d)2.17K
Avg Vol (10d)10.76K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—